Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Some nonsurgical hair loss treatments are effective, especially if started early.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Raspberry ketone lacks sufficient human research to support health benefit claims and requires more rigorous studies to confirm its safety and effectiveness.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride reduces prostate bleeding by affecting blood vessel growth.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Finasteride affects offspring's antioxidant enzymes in epididymis, possibly disrupting sperm maturation.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Dutasteride does not impair mental function in elderly men with enlarged prostate.